Spain – Antineoplastic agents – Suministro sucesivo del medicamento "Lisocabtagen Maraleucel"
awardedÁrea Sanitaria da Coruña e Cee - Servicio Gallego de Salud · Q-1569009-B
Value
€21m
Published
4 Nov 2026
Deadline
—
Type
award · framework
33652100 · Medical equipment, pharmaceuticals & personal careES111
Description
Suministro sucesivo del medicamento "Lisocabtagen Maraleucell" para el Área Sanitaria da Coruña e Cee
Key facts
- Procedure
- neg-wo-call
- Framework agreement
- Yes — a framework or dynamic purchasing system, not a single contract
- Contract period
- 30 Oct 2026 → 29 Oct 2028
- Pre-award estimate
- €21m
- Framework ceiling
- €21m
- Regime
- publicSector
- Contract references
- NA-ASC1-26-054-CON01
- Category
- supplies
Awarded suppliers
- BRISTOL-MYERS SQUIBB, S.A.U. · A28042463 · ES300, ES
Supplier location as published: Madrid, ES300, 28050, ES
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
exclusive
El contrato solo puede ser ejecutado por un operador económico particular debido a la ausencia de competencia por razones técnicas
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 765443-2026
- First seen
- 4 Nov 2026
- Last updated
- 4 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/f1341704-bb18-4689-93cc-9f83e076bb54The source notice is authoritative — verify deadlines and documents there before bidding.